Aspire Biopharma Holdings, Inc.

NasdaqGM:ASBP Stock Report

Market Cap: US$11.8m

Aspire Biopharma Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ASBP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,870,0005.87%
Institutions3,125,3136.39%
Individual Insiders12,974,88926.5%
General Public29,930,76861.2%

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.

Top Shareholders

Top 24 shareholders own 38.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.6%
Kraig Higginson
6,170,624US$1.5m0%no data
8.83%
Surendra Ajjarapu
4,317,500US$1.0m0%no data
5.87%
PowerUp Sponsor LLC
2,870,000US$689.7k0%no data
4.5%
Blackstone Inc.
2,200,886US$528.9k30.9%no data
3.42%
Lance Friedman
1,671,500US$401.7k-39.4%no data
1.15%
Ernest Scheidemann
560,963US$134.8k0%no data
0.64%
Crewe Advisors LLC
313,427US$75.3k0%0.01%
0.31%
Harraden Circle Investments, LLC
150,000US$36.0k0%0.01%
0.25%
Edward Kimball
124,658US$30.0k0%no data
0.25%
Barbara Sher
124,658US$30.0k0%no data
0.22%
Optivise Advisory Services, LLC
106,446US$25.6k0%0.02%
0.2%
Procyon Advisors, LLC
98,500US$23.7k0%no data
0.15%
Periscope Capital Inc.
75,000US$18.0k0%0.01%
0.077%
Platform Technology Partners, LLC
37,611US$9.0k0%no data
0.061%
UBS Asset Management AG
29,945US$7.2k0%no data
0.056%
Two Sigma Securities, LLC, Asset Management Arm
27,413US$6.6k0%no data
0.055%
Citadel Advisors LLC
26,901US$6.5k0%no data
0.043%
Jane Street Group, LLC, Asset Management Arm
21,019US$5.1k0%no data
0.034%
Virtu Financial LLC, Asset Management Arm
16,694US$4.0k0%no data
0.033%
Susquehanna International Group, LLP, Asset Management Arm
16,023US$3.9k0%no data
0.011%
Geode Capital Management, LLC
5,288US$1.3k0%no data
0.01%
Michael Howe
4,986US$1.2k0%no data
0.00029%
Reyes Financial Architecture, Inc
140US$34.10%no data
0.00004%
Farther Finance Advisors, LLC
20US$4.70%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/21 06:40
End of Day Share Price 2025/05/21 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aspire Biopharma Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.